Dr. Patricia Deisler completed her undergraduate studies at Columbia University
and medical degree at Weill Cornell School of Medicine in New York. She
then finished her Internal Medicine residency at St. Luke-Roosevelt Hospital
Center and Hematology-Oncology Fellowship at Cornell University Medical College.
Dr. Deisler established successful Oncology practices both at the Maine
Center for Cancer Medicine & Blood Disorders and the Mankato Clinic
in Minnesota. She served in leadership positions in a variety of institutions
that included co-director of the Breast Center and chairman of the Tumor
Board for Southern Maine Medical Center.
Dr. Deisler believes in delivering world-class cancer treatment in a loving
and caring environment for every patient.
- Columbia University, B.S. Biology
- St. Luke-Roosevelt Hospital Center, Internal Medicine Residency
- Cornell University Medical College, Department of Medicine, Hematology-Oncology
- New York Blood Center, Research Fellow, Laboratory of Hematopoietic Growth Factors
- Besmer, P., Murphy, J.E., Deisler, Patricia C., Qui Feihua, Bergold, P.J.,
Lederman, L., Snyder, H.W., Brodeur, D., Zuckerman, E.E., Hardy, W.D.
A new acute transforming feline retrovirus and Relationship of it oncogene
v-kit with the protein Kinase gene family, Nature: April 1986, 320: 415-421.
- Besmer, P., Lader, E., Deisler, Patricia C., Qui, Feihua, Bergold, P.J.,
Zuckerman, E.E., Hardy, W.D., A new acute transforming feline retrovirus
with fms Homology specifies a C-terminally truncated version Of the c-fins
protein that is different from SM-feline Virus v-fins, Journal of Virology:
Oct. 1986, 60:194-203.
Deisler, Patricia C., Morton Colman: The C3 Regimen for Resistant Lymphoma:
Daily Oral Etoposide, Chlorambucil, Proabazine and Prednisone
Proceedings of the American Society of Clinical Oncology 12 (1993), #1292 (Abstract-manuscript in press)
- Edelman, K., Miglioaccio, A.R., Deisler, Patricia C., Adamson, J., Chervevak,
F.A. Circulating Hematopoietic Stem Cell Populations in Human Fetuses:
Implications for Fetal Therapy